Ueta M, Sugama J, Konya C, Matsuo J, Matsumoto M, Yabunaka K, Nakatani T, Tabata K
Kobe City Medical Center General Hospital, Japan.
J Wound Care. 2011 Nov;20(11):503-4, 506, 508, passim. doi: 10.12968/jowc.2011.20.11.503.
To reveal the specific ultrasonic imaging findings of non-visible necrotic tissue in pressure ulcers (PUs) with undermining and describe the images objectively. The predictive validity of the specific images of the undermined necrotic tissue was also determined.
Using digital ultrasonography (12 MHz linear transducer, MyLab25; Hitachi Medical Corporation), we imaged PUs with undermining every 2 weeks. PUs were also monitored by DESIGN-R, a PU assessment tool, at the same time.
Ten patients had 11 PUs with undermining and all ulcers were located in the sacral region. The necrotic tissue showed high echogenicity with no layers, unclear borders and an uneven gray level (cloud-like image). Granulation tissue appeared as a low echoic image which had no layers, was of coarse resolution and an even gray level. There were significant differences between the pixel uniformity of the necrotic tissue (84.0) and granulation tissue (53.9) compared with uninjured tissue (65.5; p=0.000 and 0.005, respectively). The sensitivity, specificity, and positive and negative predictive values of cloud-like image were 87.5%, 91.7%, 77.8% and 95.6%, respectively.
The results suggest that cloud-like image is the most useful diagnostic indicator for non-visible necrotic tissue in PUs with undermining and is the best prognostic indicator for PU healing.
The authors have no conflicts of interest to declare. There were no external sources of funding for this study.
揭示潜行性压疮中不可见坏死组织的特定超声成像表现,并客观描述图像。还确定了潜行性坏死组织特定图像的预测效度。
使用数字超声(12MHz线性探头,MyLab25;日立医疗公司),每2周对潜行性压疮进行成像。同时使用压疮评估工具DESIGN-R对压疮进行监测。
10例患者有11处潜行性压疮,所有溃疡均位于骶部。坏死组织表现为高回声,无分层,边界不清,灰度不均(云状图像)。肉芽组织表现为低回声图像,无分层,分辨率粗糙,灰度均匀。与未损伤组织(65.5)相比,坏死组织(84.0)和肉芽组织(53.9)的像素均匀性有显著差异(分别为p=0.000和0.005)。云状图像的敏感性、特异性、阳性预测值和阴性预测值分别为87.5%、91.7%、77.8%和95.6%。
结果表明,云状图像是潜行性压疮中不可见坏死组织最有用的诊断指标,也是压疮愈合的最佳预后指标。
作者声明无利益冲突。本研究无外部资金来源。